Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

Research Square logoLink to Research Square
[Preprint]. 2024 Apr 24:rs.3.rs-4289524. [Version 1] doi: 10.21203/rs.3.rs-4289524/v1

Sustained inactivation of the Polycomb PRC1 complex induces DNA repair defects and genomic instability in epigenetic tumors

Chetan C Rawal 1, Vincent Loubiere 2, Nadejda L Butova 3, Juliette Garcia 4, Victoria Parreno 5, Anne-Marie Martinez 6, Giacomo Cavalli 7, Irene Chiolo 8
PMCID: PMC11092839  PMID: 38746379

Abstract

Cancer initiation and progression are typically associated with the accumulation of driver mutations and genomic instability. However, recent studies demonstrated that cancers can also be purely initiated by epigenetic alterations, without driver mutations. Specifically, a 24-hours transient down-regulation of polyhomeotic (ph-KD), a core component of the Polycomb complex PRC1, is sufficient to drive epigenetically initiated cancers (EICs) in Drosophila, which are proficient in DNA repair and are characterized by a stable genome. Whether genomic instability eventually occurs when PRC1 down-regulation is performed for extended periods of time remains unclear. Here we show that prolonged depletion of a PRC1 component, which mimics cancer initiating events, results in broad dysregulation of DNA replication and repair genes, along with the accumulation of DNA breaks, defective repair, and widespread genomic instability in the cancer tissue. A broad mis-regulation of H2AK118 ubiquitylation and to a lesser extent of H3K27 trimethylation also occurs, and might contribute to these phenotypes. Together, this study supports a model where DNA repair and replication defects amplify the tumorigenic transformation epigenetically induced by PRC1 loss, resulting in genomic instability and cancer progression.

Keywords: Epigenetically initiated cancers, Polycomb complex, Double-strand break repair, Genomic instability

Introduction

The tumorigenic process is typically associated with DNA damage defects and genomic instability (Hopkins, Lan and Zou 2022). However, recent studies established that cancer can also be driven purely by epigenetic changes initiated by the transient loss of the transcriptionally repressive Polycomb PRC1 complex (Parreno 2024). Polycomb Group (PcG) proteins are grouped in two main classes of complexes called Polycomb Repressive Complex 1 and 2 (PRC1 and PRC2) (Levine, Weiss et al. 2002, Kassis, Kennison and Tamkun 2017, Schuettengruber, Bourbon et al. 2017). Drosophila PRC1, which is composed of PH, PC, PSC and SCE subunits, is primarily responsible for H2AK118 ubiquitylation (H2AK118ub, or H2AK119ub in mammals) (Barbour, Daou et al. 2020, Parreno, Martinez and Cavalli 2022), whereas PRC2 mediates H3K27 trimethylation (H3K27me3) (Holoch and Margueron 2017). PRC1 and PRC2 are also highly interdependent, given that PRC1 binds to H3K27me3, and PRC2 associates with H2AK118ub (Blackledge, Farcas et al. 2014, Cooper, Grijzenhout et al. 2016, Kasinath, Beck et al. 2021). This enables cooperative binding of the two complexes to the same sites and codependency in the establishment of the respective marks on chromatin (Cooper, Grijzenhout et al. 2016, Barbour, Daou et al. 2020, Tamburri, Lavarone et al. 2020). While PRC1 and 2 form several redundant sub-complexes in mammalian cells (Parreno, Martinez and Cavalli 2022, de Potter, Raas et al. 2023), Drosophila Polycomb complexes comprise a reduced number of paralogous and accessory subunits, facilitating the study of these components in flies.

PRC1 and PRC2 co-regulate a variety of cellular processes including embryonic development, differentiation, and cell proliferation (Chan and Morey 2019, Loubiere, Martinez and Cavalli 2019, Loubiere, Papadopoulos et al. 2020). Consistent with a role for PcG proteins in cell identity, dysregulation of these components has been associated with multiple types of cancer (Piunti and Shilatifard 2021), including breast and prostate cancers, as well as hematologic malignancies (Varambally, Dhanasekaran et al. 2002, Guo, Zeng et al. 2007, Li, Li et al. 2010, Zhang, Sheng et al. 2010, Ntziachristos, Tsirigos et al. 2012, Herviou, Cavalli et al. 2016, Kim and Roberts 2016, Althobiti, Muftah et al. 2020). In agreement, PRC1 loss-of-function mutations in Drosophila result in up-regulation of major oncogenes including JAK/STAT, NOTCH and JNK signaling pathways, which are important drivers of the tumorigenic process (Classen, Bunker et al. 2009, Martinez, Schuettengruber et al. 2009, Loubiere, Delest et al. 2016, Torres, Monti et al. 2018).

Recent studies also suggest a role for PRC1 in DNA double-strand break (DSB) repair by homologous recombination (HR) and, to a lesser extent, non-homologous end joining (NHEJ) (Vissers, van Lohuizen and Citterio 2012). Upon exposure to ionizing radiation (IR) or FokI-induced DSBs, PRC1 core subunits are quickly and transiently recruited to the damage site in an ATM-dependent manner, where they induce H2A/H2AX K119ub and transcriptional silencing (Kakarougkas, Ismail et al. 2014, Kakarougkas, Downs and Jeggo 2015, Ui, Nagaura and Yasui 2015). This histone modification also promotes the recruitment of DSB repair components including 53BP1, BRCA1, RAP80, and the resection protein CtIP (Ismail, Andrin et al. 2010, Pan, Peng et al. 2011, Ismail, McDonald et al. 2013, Kakarougkas, Ismail et al. 2014, Fitieh, Locke et al. 2021, Fitieh, Locke et al. 2022). However, the extent to which DSBs strictly relies on PRC1 for repair remains unclear, as loss of this component only partially affects repair kinetics and the resulting sensitivity to IR exposure is modest (Ismail, Andrin et al. 2010, Fitieh, Locke et al. 2021).

Importantly, even a transient depletion of PRC1 core complex subunits leads to cancer formation in Drosophila (Parreno 2024). Specifically, a 24-hr depletion of the PRC1 subunit PH results in irreversible activation of key members of the JAK-STAT pathway, which in turn triggers a switch to a self-sustaining cancer cell fate, even upon restoration of normal PRC1 activity (Parreno 2024). These EICs are proficient in DSB repair and do not show chromosome rearrangements or major increase in the mutational load (Parreno 2024).

Here we investigate whether a sustained inactivation of PRC1, which mimics a cancer-inducing context, eventually results in DNA damage repair defects and genomic instability. We show that inactivation of PH over 5 days is sufficient to induce massive over-replication, the mis-regulation of several repair genes, and a broad reduction in H2AK118ub and H3K27me3. Consistently, these tumors have elevated levels of endogenous DNA damage, DSB repair defects, and massive genomic instability. Together, these results are consistent with a model where EICs derived from transient PcG inactivation can rapidly transition to a state characterized by a highly genetically unstable genome. This instability might further contribute to tumor development when Polycomb depletion is maintained.

Materials And Methods

Drosophila strains, genetics, and growth conditions

Drosophila flies were maintained on a standard corn-meal yeast extract medium at 25°C, unless otherwise indicated. Crosses were performed as described in (Parreno 2024) (See also Fig. 1). Briefly, Gal80ts was used to achieve complete depletion of PHor the control white gene by switching the temperature from 18°C to 29°C. The ey-FLP system was used to generate complete knockdowns in the larval eye-antennal imaginal discs (EDs). Flies were reared and crossed at 18°C to inhibit Gal4 activity. 6 independent crosses were set up using 80 virgin females with 20 males for each genotype and egg laying was carried out for 4 hours at 18°C to synchronize the embryonic and larval development. For achieving constant ph-and white-KD, tubes containing eggs were immediately shifted to 29°C throughout the development, and third instar larvae were dissected 5 days after egg laying (AEL). Embryos maintained at 18°C throughout and dissected 11 days AEL were also used as control (no ph-KD). The genotypes of the flies which were used to Knock-Down (KD) ph or white are as follows: For control white-KD: ey-FLP, Act-gal4 (FRT.CD2 STOP) (BL#64095); TubGal80ts (BL#7019); UAS-wRNAi (BL#33623)/UAS-GFP (BL#64095). For ph-KD: ey-FLP, Act-gal4 (FRT.CD2 STOP) (BL#64095); TubGal80ts (BL#7019); UAS-phRNAi (VDRC#50028)/UAS-GFP (BL#64095).

Figure 1: Schematic representation of the experimental setup used to induce PRC1-dependent Cancers.

Figure 1:

a) Scheme of the experimental cross used to generate progeny with thermosensitive conditional knockdown using phRNAi or whiteRNAi. Female virgins from the fly line with ey-FLP, Act-gal4, UAS-GFP were crossed with males from the fly line with tub-Gal80ts and UAS-phRNAi or UAS-wRNAi at 18°C. b) Expression of the flippase ey-FLP (pink) in imaginal eye-antennal disc cells catalyzes the FLP-out of a transcriptional stop (red) in the developing discs, allowing the expression of act-Gal4 (light blue). Constitutively expressed tub-Gal80ts (purple) encodes a temperature-sensitive Gal4 repressor. c At 18°C, TubGal80ts inhibits Gal4-mediated phRNAi as well as GFP expression (used as internal control), thereby maintaining high levels of PH, leading to normal ED development (d). Shift of the developing embryo/larvae to the restrictive temperature of 29°C for 24 h or 5 d leads to transient or constant ph-KD, respectively, thereby inducing tumors, which can be dissected at the 3rd instar stage of larval development.

Immunostaining and fluorescence microscopy

Third instar female larval heads were dissected to isolate eye-antennal imaginal discs (EDs) at RT in 1x PBS. Tissues were fixed in 4% formaldehyde for 30 minutes on a rotating wheel. Permeabilization was carried out for 1 hour in 1x PBS containing 0.5% Triton X-100 on a rotating wheel. Blocking was performed for 1 hour using 3% BSA PBTr (1x PBS + 0.1% Triton X-100), and incubated with the primary antibody against phosphorylated Histone H2AvD (Rabbit anti-Histone H2AvD pS137, dilution 1:500 prepared in 1% BSA PBTr, Rockland, 600-401-914) for 2 hours at RT. Then, samples were washed in 1x PBTr for 15 minutes each for 3 times before adding a secondary antibody (Donkey anti-rabbit Alexa Fluor 488, dilution 1:1000 in 1% BSA PBTr, Invitrogen, A-21206) for 2 hours at RT, on a rotating wheel. Tissues were then washed in PBTr for 15 minutes each for 3 times prior to DAPI staining at a final concentration of 1 μg/mL for 15 minutes. The discs were briefly washed in PBTr and in 1xPBS for 5 minutes each. Discs were mounted in Vectashield medium (Eurobio scientific, catalog no. H-1000–10) or ProLong Gold antifade agent (Life Technologies, P36930). Images for quantification of DSB foci were taken with a DeltaVision deconvolution microscope using a 60x oil immersion objective (NA 1.42 oil) and a CoolSNAP HQ2 camera. Images were processed using deconvolution through SoftWoRx 6.0.

EdU labeling to assess replication

Ethynyl-2′-deoxyuridine (EdU, thymidine analogue) labeling were performed using Click-iT Plus EdU Alexa fluor 555 Imaging kit (Invitrogen, #C10638) as per manufacturer’s instructions. The eye-antennal imaginal discs of female third instar larvae were dissected in Schneider medium and EdU was added at a final concentration of 25 μM on a rotating wheel at RT for 15 min. After washing with PBS, tissues were fixed in 4% formaldehyde 30 min and washed 3 times with PBS. The imaginal discs were permeabilized for 1h in 1xPBS + 0.5% Triton X-100 on a rotating wheel then blocked for 1h in 1xPBS + 0.1% Triton X-100 + 3% BSA. EdU detection was performed according to the manufacturer’s instructions for 30 min on a rotating wheel at RT away from light. 500 μl of Click-iT reaction solution was prepared per tube containing 10–12 eye-antennal imaginal discs. After 1xPBS + 0.1% Triton wash, DAPI staining was performed at a final concentration of 1 μg/ml during 15 min. Tissues were washes in 1xPBS + 0.1% Triton and discs were mounted in Vectashield medium. Image acquisition was performed using a Leica SP8-UV confocal microscope with a 10x objective (NA 0.4).

Fluorescent In Situ Hybridization (FISH) to analyze karyotypes

Chromosome preparation and FISH was performed as previously described (Larracuente and Ferree 2015, Ryu, Spatola et al. 2015). Eye discs and tumors from L3 female larvae were dissected in 0.7% NaCl solution and were incubated in the Colchicine solution (3 ml of 0.7% NaCl + 100 μl of 10–3 M Colchicine) for 1 hour at RT away from light. Following Colchicine treatment, tissues were incubated in 0.5% Sodium Acetate for 7 minutes, and fixed using freshly prepared 2.5% PFA in 45% acetic acid for 4 minutes on a coverslip. Tissues were pressed onto poly-lysine coated slides using manual force and snap frozen in liquid nitrogen. The slides were washed in 100% ethanol for 5 minutes, air dried and stained with FISH probes for AACAC, AATAT and 359-bp repeats, as previously described (Larracuente and Ferree 2015). Probe sequences are: 5′–6-FAM-(AACAC)7, 5′-Cy3-TTTTCCAAATTTCGGTCATCAAATAATCAT, and 5′-Cy5-(AATAT)6. Microscopy acquisition was performed on a DeltaVision deconvolution microscope using a 60x oil immersion objective (NA 1.42 oil) and a CoolSNAP HQ2 camera. Images were processed for Deconvolution using SoftWoRx 6.0.

Ionizing radiation exposure to induce DNA damage

L3 early-stage female larvae were transferred into a petri dish containing standard food medium and were irradiated with the dose of 5 Gy of X-rays using a Precision X-RAD iR160 irradiator. After irradiation, larvae were maintained in the petri dish at 29°C. Larval heads were dissected at indicated time points at RT in 1x PBS and fixed in 4% paraformaldehyde for 30 min, before immunostaining. Microscopy and image analysis were performed as described above. Due to accelerated pupation of L3 stage larvae at 29°C, DSB repair analysis was limited to 4 hours post-irradiation.

Bioinformatic analyses

All in-house bioinformatic analyses were performed in R version 3.6.3 (URL: https://www.R-project.org/) and are publicly available at https://github.com/vloubiere/Rawal_et_al_HCB_2024.git. Computations on genomic coordinate files and downstream computations were conducted using the data.table R package (data.table: Extension of ‘data.frame’. https://r-datatable.com, https://Rdatatable.gitlab.io/data.table, https://github.com/Rdatatable/data.table, v1.14.2). In all relevant panels of Figures and Extended Data Figures, box plots depict the median (line), upper and lower quartiles (box) ±1.5x interquartile range (whiskers) and outliers are not shown. For each relevant panel, the statistical test that was used is specified in the caption, and the same abbreviations were used regardless of the test: n.s.= Not significant, *pval<5e-2, **pval<1e-2, ***pval<1e-3, ****pval<1e-5.

ChIP-seq and CUT&RUN data analysis

ChIP-seq datasets and the processed data files were downloaded from GEO (GSE222193, (Parreno 2024)), and are listed Supplementary table 1. PH ChIP-seq and, H2AK118Ub and H3K27me3 CUT&RUN coverage was computed using 2.5kb bins covering all canonical chromosomes (X, 2L, 2R, 3L, 4), and were visualized using Hilbert curves (Anders 2009) and an iteration level of 10. To compute enrichment ratios around the TSS of PcG-bound genes (−25kb to +75Kb), H2AK118ub and H3K27me3 coverage was normalized to a set of activity-matched, unbound genes (n= 610 for each group).

RNA-seq data analysis

RNA-seq datasets and the processed output files were obtained from GEO (GSE222193, (Parreno 2024)), and are listed Supplementary Table 1. Differential expression analysis output performed using the DESeq2 R package (Love, Huber and Anders 2014) (v1.26.0) were obtained from ((Parreno 2024), Extended Data Table 1).

GO terms enrichment

Gene Ontology (GO) terms associated to genes that were up-regulated (padj<0.05 & log2FoldChange>1) or down-regulated (padj<0.05 & log2FoldChange>1) after constant or transient ph-KD were retrieved using the AnnnotationDbi R package (https://bioconductor.org/packages/AnnotationDbi.html, v1.48.0). For each GO term, over-representation was then assessed over a background set of genes – consisting of all the genes that passed DESeq2 initial filters – using a one-sided Fisher’s exact test (alternative = “greater”). Obtained p-values were corrected for multiple testing using False Discovery Rate (FDR).

Differentially expressed genes associated to “cellular response to DNA damage”, “DNA repair” and “DNA replication” GO terms are available in Supplementary Table 2, together with 6 other genes which were associated to the “cellular response to DNA damage stimulus”, which were nevertheless excluded from Fig. 3d due to the likelihood that their role in DNA damage response is indirect (Supplementary table 2).

Figure 3: Contrary to EICs, tumors induced by constant ph-KD display dysregulation of DNA damage response and replication associated genes.

Figure 3:

a) Representative GO terms enriched in genes differentially expressed after constant or transient ph-KD (up or down regulation) (complete list available in Supplementary Fig. 1b) b) Number of genes specifically dysregulated after constant ph-KD representing GO term DNA replication. c) EdU and nuclear staining (DAPI) of ED imaged at day 11 for no ph-KD (control, left) and tumor at day 5 for constant ph-KD (right). d) Number of genes specifically dysregulated after constant ph-KD and associated to GO terms related to the DNA damage response. e) Genome browser snapshots for representative genes upregulated only in constant ph-KD conditions showing PH, H2AK118ub and H3K27me3 normalized tracks (ChIP-seq or CUT&RUN) and gene expression by RNA-seq, in control (no ph-KD), transient ph-KD and constant ph-KD conditions.

Human and Animal Rights

The study did not involve any human or animal subjects.

Results

Prolonged loss of the core PRC1 subunit PH (ph-KD) triggers genome instability

Recent studies showed that knocking down the PRC1 subunit PH for a short time (24 h, Fig. 1, transient ph-KD) during L1 larval stage is sufficient to induce EIC formation in third instar larvae (L3), and these EICs do not exhibit DNA repair defects or genomic instability (Parreno 2024). These studies used an efficient thermosensitive ph-RNAi fly system to acutely deplete PH with a 24 h incubation at 29°C, and normal levels were restored within 48 h after switching to 18°C(Parreno 2024). The same system was used to address the effect of prolonged PRC1 inactivation (constant ph-KD), thus enabling direct comparisons with transient ph-KD. Additionally, white-KD or larvae maintained at 18°C (no ph-KD) were used as controls (Fig. 1). Constant ph-KD was obtained by incubating the larvae at 29°C during the whole larval development for 5 days. Similar to transient ph-KD(Parreno 2024), constant ph-KD also results in tumor formation in 100% of eye-antennal imaginal discs (EDs) of L3 larvae (Parreno 2024).

Prolonged ph-KD results in H2AK118ub and H3K27me3 loss at Polycomb target sites

Given that both transient and constant ph-KD results in tumors characterized by loss of polarity and differentiation, we asked whether these tumors differ at the epigenetic level. We plotted the genome-wide enrichments of PH, H2AK118ub, and H3K27me3 from control eye-antennal discs (EDs, no ph-KD), EICs after transient (24 h) ph-KD and tumors obtained after constant (5 d) ph-KD, using published ChIP-seq and CUT&RUN data sets (GSE222193 from (Parreno 2024), Supplementary table 1). As shown in Fig. 2a, Hilbert curve plotting shows that PH expression and recruitment to chromatin are restored after transient ph-KD but not after constant ph-KD. Consistently, the analysis of H2AK118ub and H3K27me3 enrichments around PRC1 target genes (PRC1-bound) relative to PRC1 non-target genes (PRC1-unbound) shows that these modifications are largely restored after transient ph-KD, but not after constant ph-KD (Fig. 2b and Supplementary Fig. 1a). The most significant difference between EICs derived from transient ph-KD and constant ph-KD tumors is associated with H2AK118ub, consistent with this histone modification being the primary modification established by PRC1. We conclude that tumors resulting from prolonged ph-KD are characterized by extensive loss of H2AK118ub and H3K27me3 at PcG target genes, while this is not the case for EICs resulting from transient ph-KD.

Figure 2: Tumors induced by constant ph-KD display loss of H2AK118ub and H3K27me3 at PcG target genes.

Figure 2:

a) Hilbert curve visualization of for PH ChIP-seq, H2AK118ub and H3K27me3 CUT&RUN in control (no ph-KD), transient ph-KD and constant ph-KD conditions. b) Enrichment ratios of H2AK118ub (left) and H3K27me3 (right) marks around the TSS (−25 to +75Kb) of PcG-bound genes compared to a control set of activity matched, PcG-unbound genes (n=610 genes for each group).

Prolonged ph-KD results in up regulation of DNA replication and DNA repair genes

Given the major epigenetic differences between EICs generated by transient and constant ph-KD, we examined the differential gene expression between these tumors compared to control tissues (no ph-KD) and temperature-matched white-KD, using the published datasets derived from RNA-seq analyses (Parreno 2024). As shown in Fig. 3a and Supplementary Fig. 1b, we found significant differences in gene expression profiles between transient and constant ph-KD tumors.

Remarkably, gene clusters corresponding to Gene Ontology (GO) terms related to DNA replication, DNA damage and DNA repair were mostly up-regulated in constant ph-KD conditions relative to transient ph-KD tumors (Fig. 3a). Consistently, a fold-change analysis of all the genes classified as “DNA replication” (n=111) or “DNA damage response” (n=242) shows a significantly higher level of transcription for both categories in constant ph-KD tumors relative to control, and also compared to all genes (Supplementary Fig. 1c). This indicates that DNA replication and DNA damage response genes are overall more transcriptionally active in tumors derived from sustained ph-KD.

Within this general trend, 21 genes required for “DNA replication” and 28 genes required for the “DNA damage response” were the most affected, displaying at least a 2-fold change in expression specifically in constant ph-KD tumors relative to controls, most of which (18 and 26 genes, respectively) were up-regulated (Fig. 3b, d).

Most of the DNA replication and DNA damage response genes up-regulated in tumors derived from constant ph-KD are not associated with PRC1 enrichments in normal tissues (no ph-KD), suggesting that they are not direct targets of PH and their up regulation is an indirect effect of PRC1 loss (e.g., Fig. 3e, CG10336, or TIPIN in mammals). The most notable exception is the replication, repair, and transcription factor Fkh (FOXA2 and FOXA1 in mammals) (Knott, Peace et al. 2012, Li, Coic et al. 2012, Dummer, Su et al. 2016, Jin, Liang and Lou 2020, Hoggard, Hollatz et al. 2021), which is enriched for PRC1 in normal tissues, suggesting that PRC1 down-regulation directly affects the transcription of this gene (Fig. 3e).

The replication genes affected in constant ph-KD tumors include key replication components: the MCM complex, origin firing factors, and several DNA polymerases (Supplementary Table 2). This might result from an overall induction of replication in the tissue. Thus, we investigated the proliferation state of the cells by EdU incorporation and labeling in these tumors. As shown in Fig. 3c, control EDs show a few replicating cells, mostly localized at the morphogenetic furrow (Avellino, Peng and Lin 2023, Parreno 2024). Conversely, tumors derived from constant ph-KD are characterized by massive EdU incorporation, indicating a complete switch to an uncontrolled over-proliferating state (Fig. 3c). Of note, DNA replication-associated genes are found over-expressed also in transient ph-KD tumors (Supplementary Fig. 1c), albeit to a lesser extent compared to constant ph-KD tumors. Similarly, transient ph-KD tumors are also highly enriched for replicating cells (Parreno 2024).

Together, these results underscore that constant ph-KD leads to tumors characterized by the upregulation of several DNA replication genes, which is likely a consequence of cell hyper-proliferation. This up-regulation is more pronounced than that observed in EICs, and might reflect an even higher proliferation rate. Upregulation of components required for replication initiation and progression can also contribute to the acquisition of the hyper-proliferative state (Yu, Wang et al. 2020). In addition, we observed dysregulation of several DNA damage response genes upon constant depletion of PH, most of which are likely the indirect consequence of PH loss. These genes are mostly expressed at normal levels in transient ph-KD tumors, representing a major difference between the effects of short-term and long-term PH depletions.

Prolonged ph-KD leads to defective DSB repair and increased genomic instability compared to EICs

DNA repair genes over-expressed in constant ph-KD tumors include several components previously linked to damage accumulation, cancer formation, and/or poor cancer prognosis (Table 1), like Mms4 (Dewalt, Kesler et al. 2014), RecQ4 (Maire, Yoshimoto et al. 2009, Su, Meador et al. 2010, Xu, Chang et al. 2021), PolH ( Tomicic, Aasland et al. 2014, Sonobe, Yang et al. 2024), Tipin/Timeless (Zhou, Zhang et al. 2020, Chen, Zhang et al. 2022), Claspin (Choi, Yang et al. 2014), MRNIP (Staples, Barone et al. 2016, Bennett, Wilkie et al. 2020, Wang, Zhao et al. 2022), FANCI (Smogorzewska, Matsuoka et al. 2007, Li, Yu et al. 2023), MMR proteins (Msh2, Mlh1, Msh6) (Shcherbakova and Kunkel 1999, Velasco, Albert et al. 2002, Li, Liu et al. 2008, Wagner, Webber et al. 2016, Wilczak, Rashed et al. 2017, Chakraborty, Dinh and Alani 2018, Donis, Gonzalez et al. 2021, Zhou, Xiao and Chen 2024), and Rif1 (Liu, Mei et al. 2018, Mei, Liu et al. 2018, Sad, Mohamed et al. 2021). Similarly, genes down regulated in constant ph-KD tumors include known components required for DNA repair and replication fork protection in the presence of replication damage, like the PCNA variant PCNA2 (Feng, Xia et al. 2023) (Table 1). Collectively, misregulation of these genes is expected to lower fork protection, increase DSB formation in response to stalled fork, and impair DSB repair.

Table 1. List of DNA repair genes dysregulated genes upon constant ph-KD.

Selected genes from supplementary table 2, their DNA repair function, mammalian homologues and link to cancer. Mismatch Repair (MMR), Base Excision Repair (BER), Nucleotide Excision Repair (NER), Translesion Synthesis (TLS).

Drosophila gene Mammalian Homologue Function in DNA repair Link to cancer

Up regulated

Mms4 EME1 Holliday Junction resolvase in complex with Mus81. Replication fork processing and repair. Overexpressed in several cancers, including colorectal and lung cancer. Associated with poor prognosis and chemo resistance.

RecQ4 RECQ4 HR repair Overexpressed in several cancers, including osteosarcomas, prostate, colorectal, and breast cancers. Associated with poor prognosis and chemo resistance.

PolH POLH Translesion polymerase Overexpressed in several cancers, including breast, lung, ovarian and bladder cancers. Associated with poor prognosis and chemoresistance.

CG43295 MRNIP HR repair through phase separation, fork protection Overexpressed in colorectal cancer, associated with radioresistance and poor prognosis.

FANCI FANCI Interstrand crosslink repair, stalled fork processing Overexpressed in several cancers, including lung adenocarcinoma, cervical cancer and liver epatocellular carcinoma, associated with poor cancer prognosis.

Spel1 MSH2 Mismatch repair, Commonly overexpressed in cancer, correlated with poor prognosis in prostate cancer.
Mlh1 MLH1 Homeologous recombination
Msh6 MSH6

Rif1 RIF1 Telomere maintenance, DSB repair (prevents resection, promoting NHEJ) Commonly overexpressed in cancer, promotes drug resistance, correlated with poor prognosis.

CG10336 TIPIN Fork protection complex, Overexpression induces cancer, promotes drug resistance, associated with poor cancer prognosis.
timeout/tim2 TIMELESS Replication stress response, Homologous recombination repair, Telomere maintenance

Claspin CLASPIN Checkpoint activation in response to replication stress Overexpression induces cancer, promotes radioresistance, associated with poor prognosis.

Down regulated

PCNA2 PCNA Sliding clamp for DNA repair in Drosophila. HR, MMR, NER, BER, TLS, Downregulated in many cancers, particularly in sarcomas and testicular cancer.

We directly tested this by investigating DNA break formation through immunofluorescence (IF) analysis of γH2Av foci in tumors dissected from L3 larvae after constant ph-KD or in EDs from the temperature-matched wRNAi control. Constant ph-KD results in a higher number of γH2Av foci in the tissue, indicating a higher level of endogenous DNA damage (Fig. 4a, b). This likely derives from the higher number of replicating cells, which typically experience a higher baseline level of damage than non-replicating cells, along with defective fork protection and repair.

Figure 4: Constant ph-KD tumors show delayed recovery after IR induced DSBs.

Figure 4:

a) Schematic representation of the kinetics experiment to assess DSB repair. b) Representative images of Drosophila cells from EDs or tumors, stained for γH2Av before (UNT) and at the indicated time points after IR, in whiteRNAi (control) and phRNAi (constant ph-KD) EDs/tumors. Nuclei were stained with DAPI (in blue). c) Number of γH2Av foci per cell before (0 min) and after irradiation (30 and 240 min) in white-KD (control) and constant ph-KD. n≥100 cells representing EDs/tumors from 3 distinct larvae and independent crosses, at the indicated time point. Error bars: SEM. Statistical significance was calculated using a two-sided t-test: ****pval<0.0005. d) Examples of karyotypes from white-KD (control) and constant ph-KD EDs/tumors of female larvae, showing examples of different genomic abnormalities. The scheme of the chromosomes shows the position of the major satellites stained by FISH. Dashed ovals: missing chromosome arms. White arrowheads: fusions. Yellow arrowhead: fusion at the pericentromeric region and abnormal number of satellites. e) Quantification of chromosome abnormalities in EDs/tumors in white-KD (control) and constant ph-KD. n ≥ 97 karyotypes representing EDs from 3 distinct larvae from independent crosses. Error bars: SEM. Statistical significance was calculated using a two-sided t-test. Scale bars = 1μm.

In addition, we investigated the DSB repair response by treating constant ph-KD tumors and their controls with 5Gy ionizing radiation (IR), and by quantifying the kinetics of γH2Av focus formation and resolution. Both tumor and ED control tissues showed a significant increase in the number of γH2Av foci 30 min after IR, indicating DSB induction and checkpoint activation. The higher level of repair foci in ph-KD tumors relative to the control reflects the higher baseline level of damage. Importantly, constant ph-KD tumors display a significantly higher number of γH2Av foci compared to control EDs 4 hours after irradiation, and this difference is much more pronounced than what observed in untreated (UNT) tissues or after 30 min from IR. This indicates that, unlike transient ph-KD tumors (Parreno 2024), constant ph-KD tumors are defective in DSB repair.

Given the higher amount of DNA damage and defective repair, we hypothesized that constant ph-KD tumors might accumulate unrepaired DSBs over time, resulting in chromosome rearrangements and genome instability. We tested this by karyotype analysis of tumors from constant ph-KD and EDs from wRNAi control in L3 larvae, using pericentromeric fluorescence in situ hybridization (FISH) probes specific for individual chromosomes (Fig. 4d). Remarkably, we observe a 4-fold increase in the frequencies of chromosome rearrangements in constant ph-KD tumors relative to the temperature-matched ED controls (Fig. 4df). Rearrangements include a large number of chromosome fusions, aneuploidies and abnormal number of satellites (Fig. 4df). Moreover, we observe a massive increase in a very rare form of rearrangements characterized by fusions across several chromosomes (“broad rearrangements”), which are so severe that they prevent clear discrimination between the chromosomes (Fig. 4df).

In conclusion, tumors induced by PH depletion over 5 days during larval stages are characterized by misregulation of genes required for fork protection and repair, DSB repair defects, and widespread genome instability, which was not observed in EICs derived from transient ph-KD.

Discussion

Although, PRC1 dysregulation is evident in several malignancies, how these tumors acquire altered genome stability remained unclear. Our comparative analysis of epigenetically initiated cancers due to transient ph-KD and tumors resulting from constant ph-KD offers a rare opportunity to identify progressive changes occurring in a developing tumor. These studies shed light on how epigenetic tumors with a stable genome can quickly transition into a state characterized by massive genomic instability through prolonged PRC1 inactivation (Fig. 5).

Figure 5: Model for tumor progression in EICs.

Figure 5:

Upon transient ph-KD, EDs switch to a hyper-proliferative cell fate notably due to an irreversible activation of the JAK-STAT pathway and zfh1 (Parreno 2024). Prolonging ph-KD for 4 additional days results in accumulation of more replication damage, misregulation of DNA damage response genes, defective DSB repair leading to persistent DNA damage. This progression reflects a cascade of events where initial hyper-proliferation leads to increased replication stress and subsequent dysregulation of DNA repair mechanisms, ultimately culminating in genome instability.

We show that, unlike transient ph-KD (Parreno 2024), constant ph-KD results in loss of H2AK118ub and H3K27me3 at Polycomb target genes, dysregulation of several DNA repair genes, marked defects in DSB repair, and widespread genome instability. Importantly, the transition to a tumor characterized by an unstable genome is reached within 5 days of PH depletion, revealing a rapid acquisition of this typical cancerous phenotype.

However, transient ph-KD tumors already display a hyper-proliferating state and some level of misregulation of replication genes. This suggests a progression of the tumor where the hyper-proliferating state is acquired first, resulting in a higher baseline level of damage, followed by dysregulation of fork protection and repair genes (including PRC1 itself), which in turn results in repair defects and chromosome rearrangements. Loss of PRC1 function can contribute to these phenotypes in non-mutually exclusive ways: i) by increasing transcription globally, thus bolstering replication stress form replication-transcription collision (Zeman and Cimprich 2014, Hamperl, Bocek et al. 2017, Gomez-Gonzalez and Aguilera 2019, Chakraborty, Schirmeisen and Lambert 2023); ii) by preventing the establishment of H2AK118ub and H3K27me3 at DSBs, thus interfering with DSB repair (Ismail, Andrin et al. 2010, Campbell, Ismail et al. 2013, Ismail, McDonald et al. 2013, Fitieh, Locke et al. 2021, Fitieh, Locke et al. 2022); and iii) by misregulating the expression of genes required for replication, DNA fork protection and DSB repair, thus increasing the accumulation of unrepaired and mis-repaired breaks. In addition, these defects are amplified in a context of a hyperproliferating tissue, with additional potential for replication damage. Collectively, tumors derived from transient or constant ph-KD represent a promising model system to investigate the gradual epigenetic and genomic changes leading to cancer formation.

Together, these observations also highlight the importance of core PRC1 subunits as tumor suppressors and guardians of genome stability. The finding that transient PRC1 depletion leads to epigenetic tumors without inducing genome instability, while prolonged inactivation of this complex results in DNA repair defects and massive rearrangements is also important to inform the strategies for cancer treatment. PRC1 has been considered a potential therapeutic target for cancer (Shukla, Ying et al. 2021, Itoh, Takada et al. 2022, Park, Qin et al. 2023) and our study suggests that PRC1 inactivation will likely increase the sensitivity of tumor cells to DNA damaging agents. On the other hand, such “epi-drugs” may also potentially transform healthy tissues into epigenetically initiated cancers and induce genome instability in response to protracted treatments. Thus, understanding how epigenetic tumors acquire a state characterized by high genome instability is important for establishing improved and safer approaches for cancer therapy.

Acknowledgments

We thank all the members of the Chiolo and Cavalli Labs for helpful discussions. We thank John Tower and Derrick Morton for access to fly incubators.

Funding Information

This work was supported by R01GM117376 and National Science Foundation Career Grant 1751197 to I.C. The laboratory of G.C. was supported by grants from the European Research Council (Advanced Grant 3DEpi, under grant agreement number 788972), the European Union (CHROMDESIGN Project, under the Marie Skłodowska-Curie grant agreement number 813327), the Fondation pour la Recherche Médicale (EQU202303016280), the MSDAVENIR foundation (project GENE-IGH), the INSERM, the Centre National pour la Recherche Scientifique, the Agence Nationale de la Recherche (E-RARE project ‘IMPACT’ and “PLASMADIFF3D” project, ANR-18-CE15–0010) and by the French National Cancer Institute (INCa PLBIO18–362).

Footnotes

Conflict of interests: The authors have no relevant financial or non-financial interests to disclose.

Additional Declarations: No competing interests reported.

Declarations

Code availability: All custom scripts were made publicly available at https://github.com/vloubiere/Rawal_et_al_HCB_2024.git

Informed consent: Not applicable.

Statements and Declarations: Not applicable.

Contributor Information

Chetan C. Rawal, University of Southern California.

Vincent Loubiere, CNRS, University of Montpellier.

Nadejda L. Butova, University of Southern California.

Juliette Garcia, CNRS, University of Montpellier.

Victoria Parreno, CNRS, University of Montpellier.

Anne-Marie Martinez, CNRS, University of Montpellier.

Giacomo Cavalli, CNRS, University of Montpellier.

Irene Chiolo, University of Southern California.

Data availability:

Data from this study will be available from the corresponding authors upon reasonable request.

References

  • 1.Althobiti M., Muftah A. A., Aleskandarany M. A., Joseph C., Toss M. S., Green A. and Rakha E. (2020). “The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes.” Breast Cancer Res Treat 182(3): 581–589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Anders S. (2009). “Visualization of genomic data with the Hilbert curve.” Bioinformatics 25(10): 1231–1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Avellino A., Peng C. H. and Lin M. D. (2023). “Cell Cycle Regulation by NF-YC in Drosophila Eye Imaginal Disc: Implications for Synchronization in the Non-Proliferative Region.” Int J Mol Sci 24(15). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Barbour H., Daou S., Hendzel M. and Affar E. B. (2020). “Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes.” Nat Commun 11(1): 5947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bennett L. G., Wilkie A. M., Antonopoulou E., Ceppi I., Sanchez A., Vernon E. G., Gamble A., Myers K. N., Collis S. J., Cejka P. and Staples C. J. (2020). “MRNIP is a replication fork protection factor.” Sci Adv 6(28): eaba5974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Blackledge N. P., Farcas A. M., Kondo T., King H. W., McGouran J. F., Hanssen L. L. P., Ito S., Cooper S., Kondo K., Koseki Y., Ishikura T., Long H. K., Sheahan T. W., Brockdorff N., Kessler B. M., Koseki H. and Klose R. J. (2014). “Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation.” Cell 157(6): 1445–1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Campbell S., Ismail I. H., Young L. C., Poirier G. G. and Hendzel M. J. (2013). “Polycomb repressive complex 2 contributes to DNA double-strand break repair.” Cell Cycle 12(16): 2675–2683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chakraborty S., Schirmeisen K. and Lambert S. A. (2023). “The multifaceted functions of homologous recombination in dealing with replication-associated DNA damages.” DNA Repair (Amst) 129: 103548. [DOI] [PubMed] [Google Scholar]
  • 9.Chakraborty U., Dinh T. A. and Alani E. (2018). “Genomic Instability Promoted by Overexpression of Mismatch Repair Factors in Yeast: A Model for Understanding Cancer Progression.” Genetics 209(2): 439–456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chan H. L. and Morey L. (2019). “Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer.” Trends Biochem Sci 44(8): 688–700. [DOI] [PubMed] [Google Scholar]
  • 11.Chen H., Zhang C., Zhou Q., Guo Y., Ren Z. and Yu Z. (2022). “Integrated Bioinformatic Analysis Identifies TIPIN as a Prognostic Biomarker in Hepatocellular Carcinoma.” Dis Markers 2022: 5764592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Choi S. H., Yang H., Lee S. H., Ki J. H., Nam D. H. and Yoo H. Y. (2014). “TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases.” Mol Cancer 13: 211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Classen A. K., Bunker B. D., Harvey K. F., Vaccari T. and Bilder D. (2009). “A tumor suppressor activity of Drosophila Polycomb genes mediated by JAK-STAT signaling.” Nat Genet 41 (10): 1150–1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cooper S., Grijzenhout A., Underwood E., Ancelin K., Zhang T., Nesterova T. B., Anil-Kirmizitas B., Bassett A., Kooistra S. M., Agger K., Helin K., Heard E. and Brockdorff N. (2016). “Jarid2 binds mono-ubiquitylated H2A lysine 119 to mediate crosstalk between Polycomb complexes PRC1 and PRC2.” Nat Commun 7: 13661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.de Potter B., Raas M. W. D., Seidl M. F., Verrijzer C. P. and Snel B. (2023). “Uncoupled evolution of the Polycomb system and deep origin of non-canonical PRC1.” Communications Biology 6(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dewalt R. I., Kesler K. A., Hammoud Z. T., Baldridge L., Hattab E. M. and Jalal S. I. (2014). “Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair.” Lung Cancer (Auckl) 5: 11–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Donis S. P., Gonzalez A. P., Alves M. G. O., do Carmo Carvalho B. F., Ferreira C. C. P., Almeida J. D., Iruegas E. P., Petronacci C. M. C., Penaranda J. M. S. and Sayans M. P. (2021). “MLH1, MSH2, MRE11, and XRCC1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma.” Appl Immunohistochem Mol Morphol 29(8): 613–618. [DOI] [PubMed] [Google Scholar]
  • 18.Dummer A. M., Su Z., Cherney R., Choi K., Denu J., Zhao X. and Fox C. A. (2016). “Binding of the Fkh1 Forkhead Associated Domain to a Phosphopeptide within the Mph1 DNA Helicase Regulates Mating-Type Switching in Budding Yeast.” PLoS Genet 12(6): e1006094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Feng Y., Xia S., Hui J. and Xu Y. (2023). “Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217/high mobility group AT-hook 2 (HMGA2) axis.” Heliyon 9(6): e17120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fitieh A., Locke A. J., Mashayekhi F., Khaliqdina F., Sharma A. K. and Ismail I. H. (2022). “BMI-1 regulates DNA end resection and homologous recombination repair.” Cell Rep 38(12): 110536. [DOI] [PubMed] [Google Scholar]
  • 21.Fitieh A., Locke A. J., Motamedi M. and Ismail I. H. (2021). “The Role of Polycomb Group Protein BMI1 in DNA Repair and Genomic Stability.” Int J Mol Sci 22(6). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gomez-Gonzalez B. and Aguilera A. (2019). “Transcription-mediated replication hindrance: a major driver of genome instability.” Genes Dev 33(15–16): 1008–1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Guo W. J., Zeng M. S., Yadav A., Song L. B., Guo B. H., Band V. and Dimri G. P. (2007). “Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells.” Cancer Res 67(11): 5083–5089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hamperl S., Bocek M. J., Saldivar J. C., Swigut T. and Cimprich K. A. (2017). “Transcription-Replication Conflict Orientation Modulates R-Loop Levels and Activates Distinct DNA Damage Responses.” Cell 170(4): 774–786 e719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Herviou L., Cavalli G., Cartron G., Klein B. and Moreaux J. (2016). “EZH2 in normal hematopoiesis and hematological malignancies.” Oncotarget 7(3): 2284–2296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hoggard T., Hollatz A. J., Cherney R. E., Seman M. R. and Fox C. A. (2021). “The Fkh1 Forkhead associated domain promotes ORC binding to a subset of DNA replication origins in budding yeast.” Nucleic Acids Res 49(18): 10207–10220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Holoch D. and Margueron R. (2017). “Mechanisms Regulating PRC2 Recruitment and Enzymatic Activity.” Trends Biochem Sci 42(7): 531–542. [DOI] [PubMed] [Google Scholar]
  • 28.Hopkins J. L., Lan L. and Zou L. (2022). “DNA repair defects in cancer and therapeutic opportunities.” Genes Dev 36(5–6): 278–293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ismail I. H., Andrin C., McDonald D. and Hendzel M. J. (2010). “BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair.” J Cell Biol 191(1): 45–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ismail I. H., McDonald D., Strickfaden H., Xu Z. and Hendzel M. J. (2013). “A small molecule inhibitor of polycomb repressive complex 1 inhibits ubiquitin signaling at DNA double-strand breaks.” J Biol Chem 288(37): 26944–26954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Itoh Y., Takada Y., Yamashita Y. and Suzuki T. (2022). “Recent progress on small molecules targeting epigenetic complexes.” Curr Opin Chem Biol 67: 102130. [DOI] [PubMed] [Google Scholar]
  • 32.Jin Y., Liang Z. and Lou H. (2020). “The Emerging Roles of Fox Family Transcription Factors in Chromosome Replication, Organization, and Genome Stability.” Cells 9(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kakarougkas A., Downs J. A. and Jeggo P. A. (2015). “The PBAF chromatin remodeling complex represses transcription and promotes rapid repair at DNA double-strand breaks.” Mol Cell Oncol 2(1): e970072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kakarougkas A., Ismail A., Chambers A. L., Riballo E., Herbert A. D., Kunzel J., Lobrich M., Jeggo P. A. and Downs J. A. (2014). “Requirement for PBAF in transcriptional repression and repair at DNA breaks in actively transcribed regions of chromatin.” Mol Cell 55(5): 723–732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kasinath V., Beck C., Sauer P., Poepsel S., Kosmatka J., Faini M., Toso D., Aebersold R. and Nogales E. (2021). “JARID2 and AEBP2 regulate PRC2 in the presence of H2AK119ub1 and other histone modifications.” Science 371 (6527). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kassis J. A., Kennison J. A. and Tamkun J. W. (2017). “Polycomb and Trithorax Group Genes in Drosophila.” Genetics 206(4): 1699–1725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kim K. H. and Roberts C. W. (2016). “Targeting EZH2 in cancer.” Nat Med 22(2): 128–134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Knott S. R., Peace J. M., Ostrow A. Z., Gan Y., Rex A. E., Viggiani C. J., Tavare S. and Aparicio O. M. (2012). “Forkhead transcription factors establish origin timing and long-range clustering in S. cerevisiae.” Cell 148(1–2): 99–111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Larracuente A. M. and Ferree P. M. (2015). “Simple method for fluorescence DNA in situ hybridization to squashed chromosomes.” J Vis Exp(95): 52288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Levine S. S., Weiss A., Erdjument-Bromage H., Shao Z., Tempst P. and Kingston R. E. (2002). “The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans.” Mol Cell Biol 22(17): 6070–6078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Li J., Coic E., Lee K., Lee C. S., Kim J. A., Wu Q. and Haber J. E. (2012). “Regulation of budding yeast mating-type switching donor preference by the FHA domain of Fkh1.” PLoS Genet 8(4): e1002630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Li M., Liu L., Wang Z., Wang L., Liu Z., Xu G. and Lu S. (2008). “Overexpression of hMSH2 and hMLH1 protein in certain gastric cancers and their surrounding mucosae.” Oncol Rep 19(2): 401–406. [PubMed] [Google Scholar]
  • 43.Li W., Li Y., Tan Y., Ma K. and Cui J. (2010). “Bmi-1 is critical for the proliferation and invasiveness of gastric carcinoma cells.” J Gastroenterol Hepatol 25(3): 568–575. [DOI] [PubMed] [Google Scholar]
  • 44.Li W., Yu M., Zhang J., Huang J., Lin Z., Chen J., Jiang G. and Lin X. (2023). “High expression levels of FANCI correlate with worse prognosis and promote tumor growth of lung adenocarcinoma partly via suppression of M1 macrophages.” Gene 851 : 147053. [DOI] [PubMed] [Google Scholar]
  • 45.Liu Y. B., Mei Y., Long J., Zhang Y., Hu D. L. and Zhou H. H. (2018). “RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.” J Exp Clin Cancer Res 37(1): 182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Loubiere V., Delest A., Thomas A., Bonev B., Schuettengruber B., Sati S., Martinez A. M. and Cavalli G. (2016). “Coordinate redeployment of PRC1 proteins suppresses tumor formation during Drosophila development.” Nat Genet 48(11): 1436–1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Loubiere V., Martinez A. M. and Cavalli G. (2019). “Cell Fate and Developmental Regulation Dynamics by Polycomb Proteins and 3D Genome Architecture.” Bioessays 41 (3): e1800222. [DOI] [PubMed] [Google Scholar]
  • 48.Loubiere V., Papadopoulos G. L., Szabo Q., Martinez A. M. and Cavalli G. (2020). “Widespread activation of developmental gene expression characterized by PRC1-dependent chromatin looping.” Sci Adv 6(2): eaax4001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Love M. I., Huber W. and Anders S. (2014). “Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.” Genome Biol 15(12): 550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Maire G., Yoshimoto M., Chilton-MacNeill S., Thorner P. S., Zielenska M. and Squire J. A. (2009). “Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma.” Neoplasia 11(3): 260–268, 263p following 268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Martinez A. M., Schuettengruber B., Sakr S., Janic A., Gonzalez C. and Cavalli G. (2009). “Polyhomeotic has a tumor suppressor activity mediated by repression of Notch signaling.” Nat Genet 41 (10): 1076–1082. [DOI] [PubMed] [Google Scholar]
  • 52.Mei Y., Liu Y. B., Cao S., Tian Z. W. and Zhou H. H. (2018). “RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/beta-catenin signaling.” Cell Death Dis 9(10): 942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Ntziachristos P., Tsirigos A., Van Vlierberghe P., Nedjic J., Trimarchi T., Flaherty M. S., Ferres-Marco D., da Ros V., Tang Z., Siegle J., Asp P., Hadler M., Rigo I., De Keersmaecker K., Patel J., Huynh T., Utro F., Poglio S., Samon J. B., Paietta E., Racevskis J., Rowe J. M., Rabadan R., Levine R. L., Brown S., Pflumio F., Dominguez M., Ferrando A. and Aifantis I. (2012). “Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia.” Nat Med 18(2): 298–301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Pan M. R., Peng G., Hung W. C. and Lin S. Y. (2011). “Monoubiquitination of H2AX protein regulates DNA damage response signaling.” J Biol Chem 286(32): 28599–28607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Park K. S., Qin L., Kabir M., Luo K., Dale B., Zhong Y., Kim A., Wang G. G., Kaniskan H. U. and Jin J. (2023). “Targeted Degradation of PRC1 Components, BMI1 and RING1B, via a Novel Protein Complex Degrader Strategy.” Adv Sci (Weinh) 10(10): e2205573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Parreno V., Loubiere V., Schuettengruber B., Fritsch L., Rawal C. C., Erokhin M., Győrffy B., Normanno D., Di Stefano M., Moreaux J., Butova N. L., Chiolo I., Chetverina D., Martinez A-M. & Cavalli G. (2024). “Transient loss of Polycomb components induces an epigenetic cancer fate.” Nature: In press. DOI: 10.1038/s41586-024-07328-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Parreno V., Martinez A. M. and Cavalli G. (2022). “Mechanisms of Polycomb group protein function in cancer.” Cell Res 22(3): 231–253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Piunti A. and Shilatifard A. (2021). “The roles of Polycomb repressive complexes in mammalian development and cancer.” Nat Rev Mol Cell Biol 22(5): 326–345. [DOI] [PubMed] [Google Scholar]
  • 59.Ryu T., Spatola B., Delabaere L., Bowlin K., Hopp H., Kunitake R., Karpen G. H. and Chiolo I. (2015). “Heterochromatic breaks move to the nuclear periphery to continue recombinational repair.” Nat Cell Biol 17(11): 1401–1411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Sad L., Mohamed D. A., Elanwar N. M. and Elkady A. (2021). “CXCR4 and RIF1 overexpression induces resistance of epithelial ovarian cancer to cisplatin-based chemotherapy.” J Cancer Res Ther 17(6): 1454–1461. [DOI] [PubMed] [Google Scholar]
  • 61.Schuettengruber B., Bourbon H. M., Di Croce L. and Cavalli G. (2017). “Genome Regulation by Polycomb and Trithorax: 70 Years and Counting.” Cell 171(1): 34–57. [DOI] [PubMed] [Google Scholar]
  • 62.Shcherbakova P. V. and Kunkel T. A. (1999). “Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations.” Mol Cell Biol 19(4): 3177–3183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Shukla S., Ying W., Gray F., Yao Y., Simes M. L., Zhao Q., Miao H., Cho H. J., Gonzalez-Alonso P., Winkler A., Lund G., Purohit T., Kim E., Zhang X., Ray J. M., He S., Nikolaidis C., Ndoj J., Wang J., Jaremko L., Jaremko M., Ryan R. J. H., Guzman M. L., Grembecka J. and Cierpicki T. (2021). “Small-molecule inhibitors targeting Polycomb repressive complex 1 RING domain.” Nat Chem Biol 17(7): 784–793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Smogorzewska A., Matsuoka S., Vinciguerra P., McDonald E. R. 3rd, Hurov K. E., Luo J., Ballif B. A., Gygi S. P., Hofmann K., D’Andrea A. D. and Elledge S. J. (2007). “Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair.” Cell 129(2): 289–301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Sonobe R., Yang P., Suzuki M. M., Shinjo K., Iijima K., Nishiyama N., Miyata K., Kataoka K., Kajiyama H. and Kondo Y. (2024). “Long noncoding RNA TUG1 promotes cisplatin resistance in ovarian cancer via upregulation of DNA polymerase eta.” Cancer Sci. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Staples C. J., Barone G., Myers K. N., Ganesh A., Gibbs-Seymour I., Patil A. A., Beveridge R. D., Daye C., Beniston R., Maslen S., Ahel I., Skehel J. M. and Collis S. J. (2016). “MRNIP/C5orf45 Interacts with the MRN Complex and Contributes to the DNA Damage Response.” Cell Rep 16(10): 2565–2575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Su Y., Meador J. A., Calaf G. M., Proietti De-Santis L., Zhao Y., Bohr V. A. and Balajee A. S. (2010). “Human RecQL4 helicase plays critical roles in prostate carcinogenesis.” Cancer Res 70(22): 9207–9217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Tamburri S., Lavarone E., Fernandez-Perez D., Conway E., Zanotti M., Manganaro D. and Pasini D. (2020). “Histone H2AK119 Mono-Ubiquitination Is Essential for Polycomb-Mediated Transcriptional Repression.” Mol Cell 77(4): 840–856 e845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Tomicic M. T., Aasland D., Naumann S. C., Meise R., Barckhausen C., Kaina B. and Christmann M. (2014). “Translesion polymerase eta is upregulated by cancer therapeutics and confers anticancer drug resistance.” Cancer Res 74(19): 5585–5596. [DOI] [PubMed] [Google Scholar]
  • 70.Torres J., Monti R., Moore A. L., Seimiya M., Jiang Y., Beerenwinkel N., Beisel C., Beira J. V. and Paro R. (2018). “A switch in transcription and cell fate governs the onset of an epigenetically-deregulated tumor in Drosophila.” Elife 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Ui A., Nagaura Y. and Yasui A. (2015). “Transcriptional elongation factor ENL phosphorylated by ATM recruits polycomb and switches off transcription for DSB repair.” Mol Cell 58(3): 468–482. [DOI] [PubMed] [Google Scholar]
  • 72.Varambally S., Dhanasekaran S. M., Zhou M., Barrette T. R., Kumar-Sinha C., Sanda M. G., Ghosh D., Pienta K. J., Sewalt R. G., Otte A. P., Rubin M. A. and Chinnaiyan A. M. (2002). “The polycomb group protein EZH2 is involved in progression of prostate cancer.” Nature 419(6907): 624–629. [DOI] [PubMed] [Google Scholar]
  • 73.Velasco A., Albert P. S., Rosenberg H., Martinez C. and Leach F. S. (2002). “Clinicopathologic implications of hMSH2 gene expression and microsatellite instability in prostate cancer.” Cancer Biol Ther 1 (4): 362–367. [PubMed] [Google Scholar]
  • 74.Vissers J. H., van Lohuizen M. and Citterio E. (2012). “The emerging role of Polycomb repressors in the response to DNA damage.” J Cell Sci 125(Pt 17): 3939–3948. [DOI] [PubMed] [Google Scholar]
  • 75.Wagner V. P., Webber L. P., Salvadori G., Meurer L., Fonseca F. P., Castilho R. M., Squarize C. H., Vargas P. A. and Martins M. D. (2016). “Overexpression of MutSalpha Complex Proteins Predicts Poor Prognosis in Oral Squamous Cell Carcinoma.” Medicine (Baltimore) 95(22): e3725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Wang Y. L., Zhao W. W., Bai S. M., Feng L. L., Bie S. Y., Gong L., Wang F., Wei M. B., Feng W. X., Pang X. L., Qin C. L., Yin X. K., Wang Y. N., Zhou W., Wahl D. R., Liu Q., Chen M., Hung M. C. and Wan X. B. (2022). “MRNIP condensates promote DNA double-strand break sensing and end resection.” Nat Commun 13(1): 2638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Wilczak W., Rashed S., Hube-Magg C., Kluth M., Simon R., Buscheck F., Clauditz T. S., Grupp K., Minner S., Tsourlakis M. C., Moller-Koop C., Graefen M., Adam M., Haese A., Wittmer C., Sauter G., Izbicki J. R., Huland H., Schlomm T., Steurer S., Krech T. and Lebok P. (2017). “Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.” Carcinogenesis 38(1): 19–27. [DOI] [PubMed] [Google Scholar]
  • 78.Xu X., Chang C. W., Li M., Liu C. and Liu Y. (2021). “Molecular Mechanisms of the RECQ4 Pathogenic Mutations.” Front Mol Biosci 8: 791194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Yu S., Wang G., Shi Y., Xu H., Zheng Y. and Chen Y. (2020). “MCMs in Cancer: Prognostic Potential and Mechanisms.” Anal Cell Pathol (Amst) 2020: 3750294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Zeman M. K. and Cimprich K. A. (2014). “Causes and consequences of replication stress.” Nat Cell Biol 16(1): 2–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Zhang X. W., Sheng Y. P., Li Q., Qin W., Lu Y. W., Cheng Y. F., Liu B. Y., Zhang F. C., Li J., Dimri G. P. and Guo W. J. (2010). “BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.” Mol Cancer 9: 40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Zhou J., Zhang Y., Zou X., Kuai L., Wang L., Wang J., Shen F., Hu J., Zhang X., Huang Y. and Chen Y. (2020). “Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer.” Hum Gene Ther 31 (5–6): 385–395. [DOI] [PubMed] [Google Scholar]
  • 83.Zhou L. Z., Xiao H. Q. and Chen J. (2024). “Mismatch repair gene MSH6 correlates with the prognosis, immune status and immune checkpoint inhibitors response of endometrial cancer.” Front Immunol 15: 1302797. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data from this study will be available from the corresponding authors upon reasonable request.


Articles from Research Square are provided here courtesy of American Journal Experts

RESOURCES